| Schedule of summarized financial information | 
   |      
 |    For the Three Months Ended March 31, 2020 (Unaudited) (in thousands) 
 |   | 
    |      
 |    Cannabis 
 |   |      
 |    Other / Corporate 
 |   |      
 |    Total  
 |   | 
    |   |   |   |   |   |   |   |   |      
 | 
   |   Total Revenues 
 |      
 |    $ 
 |    3,746 
 |   |      
 |    $ 
 |    567 
 |   |      
 |    $ 
 |    4,313 
 |      
 | 
   |   Cost of Goods Sold 
 |   |      
 |    1,422 
 |   |   |      
 |    553 
 |   |   |      
 |    1,975 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Gross Profit 
 |   |      
 |    2,324 
 |   |   |      
 |    14 
 |   |   |      
 |    2,338 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Selling, General and Administrative Expenses 
 |   |      
 |    3,878 
 |   |   |      
 |    5,159 
 |   |   |      
 |    9,037 
 |      
 | 
   |   Impairment of Assets 
 |   |      
 |    5,120 
 |   |   |      
 |    - 
 |   |   |      
 |    5,120 
 |      
 | 
   |   (Gain) / Loss on Sale of Assets 
 |   |      
 |    (35 
 |    ) 
 |   |      
 |    - 
 |   |   |      
 |    (35 
 |    ) 
 | 
   |   (Gain) / Loss on Interest in Joint Venture 
 |   |      
 |    - 
 |   |   |      
 |    - 
 |   |   |      
 |    - 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Loss from operations 
 |   |      
 |    (6,639 
 |    ) 
 |   |      
 |    (5,145 
 |    ) 
 |   |      
 |    (11,784 
 |    ) 
 | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Other Income (Expense): 
 |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Interest Income (Expense) 
 |   |      
 |    (245 
 |    ) 
 |   |      
 |    (657 
 |    ) 
 |   |      
 |    (902 
 |    ) 
 | 
   |   Other Income / (Loss) 
 |   |      
 |    38 
 |   |   |      
 |    27 
 |   |   |      
 |    65 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Total Other Income (Expense) 
 |   |      
 |    (207 
 |    ) 
 |   |      
 |    (630 
 |    ) 
 |   |      
 |    (837 
 |    ) 
 | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Income (loss) from subsidiaries 
 |   |      
 |    - 
 |   |   |      
 |    - 
 |   |   |      
 |    - 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Net Income (Loss) from continuing operations 
 |      
 |    $ 
 |    (6,846 
 |    ) 
 |      
 |    $ 
 |    (5,775 
 |    ) 
 |      
 |    $ 
 |    (12,621 
 |    ) 
 | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Total assets at March 31, 2020 
 |      
 |    $ 
 |    49,915 
 |   |      
 |    $ 
 |    65,071 
 |   |      
 |    $ 
 |    114,986 
 |   | 
 
    
   |      
 |    For the Three Months Ended March 31, 2019 (Unaudited) (in thousands) 
 |   | 
    |      
 |    Cannabis 
 |   |      
 |    Other / Corporate 
 |   |      
 |    Total  
 |   | 
    |   |   |   |   |   |   |   |   |      
 | 
   |   Total Revenues 
 |      
 |    $ 
 |    2,045 
 |   |      
 |    $ 
 |    - 
 |   |      
 |    $ 
 |    2,045 
 |      
 | 
   |   Cost of Goods Sold 
 |   |      
 |    445 
 |   |   |      
 |    - 
 |   |   |      
 |    445 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Gross Profit 
 |   |      
 |    1,600 
 |   |   |      
 |    - 
 |   |   |      
 |    1,600 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Selling, General and Administrative Expenses 
 |   |      
 |    3,052 
 |   |   |      
 |    5,539 
 |   |   |      
 |    8,591 
 |      
 | 
   |   Impairment of Assets 
 |   |      
 |    - 
 |   |   |      
 |    - 
 |   |   |      
 |    - 
 |      
 | 
   |   (Gain) / Loss on Sale of Assets 
 |   |      
 |    - 
 |   |   |      
 |    - 
 |   |   |      
 |    - 
 |      
 | 
   |   (Gain) / Loss on Interest in Joint Venture 
 |   |      
 |    1,067 
 |   |   |      
 |    - 
 |   |   |      
 |    1,067 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Loss from operations 
 |   |      
 |    (2,519 
 |    ) 
 |   |      
 |    (5,539 
 |    ) 
 |   |      
 |    (8,058 
 |    ) 
 | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Other Income (Expense): 
 |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Interest Income (Expense) 
 |   |      
 |    (227 
 |    ) 
 |   |      
 |    (2,701 
 |    ) 
 |   |      
 |    (2,928 
 |    ) 
 | 
   |   Other Income / (Loss) 
 |   |      
 |    - 
 |   |   |      
 |    11 
 |   |   |      
 |    11 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Total Other Income (Expense) 
 |   |      
 |    (227 
 |    ) 
 |   |      
 |    (2,690 
 |    ) 
 |   |      
 |    (2,917 
 |    ) 
 | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Income (loss) from subsidiaries 
 |   |      
 |    - 
 |   |   |      
 |    - 
 |   |   |      
 |    - 
 |   | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Net Income (Loss) from continuing operations 
 |      
 |    $ 
 |    (2,746 
 |    ) 
 |      
 |    $ 
 |    (8,229 
 |    ) 
 |      
 |    $ 
 |    (10,975 
 |    ) 
 | 
    |   |   |   |   |   |   |   |   |   |   |   |      
 | 
   |   Total assets at March 31, 2019 
 |      
 |    $ 
 |    41,862 
 |   |      
 |    $ 
 |    77,388 
 |   |      
 |    $ 
 |    119,250 
 |   | 
 
 
 
 |